AKT2 signaling is renoprotective in T1D by enhancing antioxidant signaling with AMPK activation (Cheng et al., 2020) and promotes podocyte viability in chronic kidney disease (Canaud et al., 2013). This evidence concerns the gene AKT2 and chronic kidney disease.